Gross haematuria after mRNA COVID‐19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy

COVID-19 vaccination safety in those with known vasculitis. The scarcity of cases contrasted with the number of vaccines given is reassuring and should not change our practice in recommending vaccination to our patients; however, it would be prudent to monitor those with a history of vasculitis closely. Regarding the cases described here, recommending an alternative vaccination for future doses may be a sensible path forward.